Transdermally absorbed preparation of anti-dementia drug
一种制剂、痴呆的技术,应用在药物组合、非有效成分的医用配制品、含有效成分的医用配制品等方向,能够解决药物透过性低、吸收困难等问题,达到抑制皮肤刺激的效果
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0084] Preparation of drug-containing layer
[0085] Prepare Donepezil, Eudragit according to the ratio of the following prescription (注册商标) E 100, triethyl citrate, IPM (isopropyl myristate) and SML (sorbitan monolaurate), they are mixed and stirred in an appropriate amount of toluene. Add SIS (styrene-isoprene-styrene block copolymer, Kraton (注册商标) D1111K, manufactured by Kraton Corporation), ALCON P-100 (manufactured by Arakawa Chemical Industry Co., Ltd.), and a paste solution was obtained.
[0086] [Table 1]
[0087]
[0088]The above paste solution was coated on a polyethylene terephthalate liner, and dried at 80° C. for 15 minutes to obtain a drug-containing layer. Adjusted so that the amount of the dried drug-containing layer is 50 g / m 2 .
[0089] Then, the upper support (Scotchpak (商标) 9732, manufactured by 3M), to obtain a transdermal preparation.
Embodiment 2
[0091] A percutaneous absorption preparation was prepared in the same manner as in Example 1 except that the formulation was changed as described below.
[0092] [Table 2]
[0093]
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com